GPR180, also known as G protein-coupled receptor 180, is an orphan receptor that belongs to the family of G protein-coupled receptors (GPCRs). GPCRs are a large and diverse group of membrane proteins that respond to a variety of extracellular signals, including hormones, neurotransmitters, and environmental stimuli, and transduce these signals into cellular responses, often through the activation of intracellular G proteins.
The designation "orphan receptor" indicates that the endogenous ligand, or natural activating molecule, for GPR180 has not been conclusively identified. This lack of information about its ligand greatly limits the understanding of GPR180's physiological and pathophysiological roles. However, the structural features that GPR180 shares with other GPCRs suggest that it could be involved in similar signaling mechanisms once its ligand is discovered.GPR180 is distinct from other GPCRs in its sequence and is classified within its own unique group within the GPCR superfamily. It is encoded by the GPR180 gene and is expressed in various tissues, although its expression pattern and the regulation of its activity are not fully characterized.
Items 11 to 12 of 12 total
디스플레이 라벨:
제품명 | CAS # | 카탈로그 번호 | 수량 | 가격 | 引用 | RATING |
---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
리튬은 GSK-3 신호에 영향을 미쳐 간접적으로 GPR180의 발현을 강화할 수 있습니다. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $118.00 $320.00 $622.00 $928.00 $1234.00 | 38 | |
로시글리타존은 PPAR-감마를 활성화하여 PPAR-감마 반응 요소를 통해 GPR180 발현을 증가시킬 수 있습니다. |